Comparison of the clinical performance of the modified Marsh model for propofol between underweight and normal-weight patients with Crohn's disease.

Soo-Kyung Park Ji Hyun Park Hyun Uk Kang Byung-Moon Choi Gyu-Jeong Noh

Published in: Korean journal of anesthesiology (2017)

The modified Marsh model might cause inadvertent propofol underdosing in underweight patients. Future studies are necessary to compare the predictive performance of the modified Marsh and Schnider pharmacokinetic models in underweight patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported outcomes
patient reported
current status
body weight